MedPath

Coronary Disease and the Effect of High-intensity Interval Training

Not Applicable
Completed
Conditions
Coronary Disease
Interventions
Behavioral: high intensity interval-based aerobic exercise
Other: Usual care
Registration Number
NCT02494947
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The primary purpose of this study is to investigate if systematic, high intensity, interval-based aerobic exercise training results in regression of lipid content of atherosclerotic coronary artery plaques, and in reduction of plaque burden in patients with stable coronary heart disease. Composition and morphologic characteristics of plaques will be studied by intra-coronary near-infrared spectroscopy (NIRS) and intravascular ultrasound (IVUS) in patients undergoing percutaneous coronary intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • stable coronary artery disease
  • will undergo cardiac catheterization
  • will be treated with percutaneous coronary intervention (PCI)
  • signed written informed consent
  • able to execute the intervention
Exclusion Criteria
  • earlier bypass surgery
  • known inflammatory disease other than atherosclerosis
  • planned surgery within 4 months
  • included in another randomized controlled study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
interval trainingUsual carehigh intensity interval-based aerobic exercise
controlsUsual careusual care
interval traininghigh intensity interval-based aerobic exercisehigh intensity interval-based aerobic exercise
Primary Outcome Measures
NameTimeMethod
lipid content of atherosclerotic coronary artery plaques6 months

Lipid core burden index (LCBI) measured by intracoronary near-infrared spectroscopy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

St Olavs Hospital

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath